1. Home
  2. RNG vs AMPH Comparison

RNG vs AMPH Comparison

Compare RNG & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RingCentral Inc.

RNG

RingCentral Inc.

HOLD

Current Price

$29.59

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.63

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNG
AMPH
Founded
1999
1996
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
1.3B
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
RNG
AMPH
Price
$29.59
$26.63
Analyst Decision
Hold
Buy
Analyst Count
14
6
Target Price
$31.23
$31.00
AVG Volume (30 Days)
1.3M
373.9K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
2.27
Revenue
$2,485,621,000.00
$723,305,000.00
Revenue This Year
$5.73
$1.35
Revenue Next Year
$4.49
$5.10
P/E Ratio
$210.14
$11.68
Revenue Growth
5.45
N/A
52 Week Low
$20.59
$20.39
52 Week High
$39.59
$41.13

Technical Indicators

Market Signals
Indicator
RNG
AMPH
Relative Strength Index (RSI) 52.98 53.43
Support Level $29.05 $25.16
Resistance Level $30.70 $26.50
Average True Range (ATR) 0.89 0.87
MACD -0.04 -0.04
Stochastic Oscillator 28.41 54.88

Price Performance

Historical Comparison
RNG
AMPH

About RNG RingCentral Inc.

RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: